Mirae Asset Global Investments Co., Ltd. Precigen, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,406 shares of PGEN stock, worth $9,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,406
Previous 7,536
38.08%
Holding current value
$9,885
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PGEN
# of Institutions
140Shares Held
145MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$79.3 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$17.3 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$9.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.76MShares$6.42 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$3.59 Million0.8% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $198M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...